Netherlands· NL-db4c31e5abd0

Emtricitabine/rilpivirine/tenofoviralafenamide Viatris 200 mg/25 mg/25 mg filmomhulde tabletten.

A emtricitabine, tenofovir alafenamide and rilpivirine product containing emtricitabine + rilpivirinehydrochloride + tenofoviralafenamidemonofumaraat, registered in Netherlands by Viatris Limited. The same ATC class is registered in 13 of our 19 countries.

ATC J05AR19

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about emtricitabine + rilpivirinehydrochloride + tenofoviralafenamidemonofumaraatAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Emtricitabine, tenofovir alafenamide and rilpivirine is registered in 13 of 19 countries.

Countries holding a registration under ATC J05AR19 (emtricitabine, tenofovir alafenamide and rilpivirine), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
8 of them publish a price we can compare per daily dose

Search emtricitabine, tenofovir alafenamide and rilpivirine products by name

Emtricitabine, tenofovir alafenamide and rilpivirine · ATC J05AR19

13 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Icelandprice
Ireland
Netherlands
Norwayprice
Polandprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)

Active substance: EMTRICITABINE + RILPIVIRINEHYDROCHLORIDE + TENOFOVIRALAFENAMIDEMONOFUMARAAT
Manufacturer: Viatris Limited
Country: Netherlands (NL)
ATC code: J05AR19
ATC class: Emtricitabine, tenofovir alafenamide and rilpivirine
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
EU/1/25/1966

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Emtricitabine, tenofovir alafenamide and rilpivirine in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All emtricitabine, tenofovir alafenamide and rilpivirine products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

Iceland · Emtricitabine/Rilpivirine/Tenofovir Alafenamide Viatris, Odefsey
Liechtenstein · Emtricitabine/Rilpivirine/Tenofovir Alafenamide Viatris, Odefsey
Norway · Emtricitabine/Rilpivirine/Tenofovir Alafenamide Viatris, Odefsey

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/b869d60f-d659-4b7c-ba1e-bb683a9c586b
GET /v1/drugs/b869d60f-d659-4b7c-ba1e-bb683a9c586b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/emtricitabine-rilpivirine-tenofovir-alafenamide-viatris-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Emtricitabine, tenofovir alafenamide and rilpivirine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp133776",
  "excipients": [
    "CALCIUMCARBONAAT (E 170)",
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "CROSCARMELLOSE  NATRIUM  (E 468)",
    "LACTOSE 1-WATER",
    "MACROGOL 3350",
    "MAGNESIUMSTEARAAT (E 470b)",
    "MAÏSZETMEEL",
    "POLYVINYLALCOHOL (E 1203)",
    "POVIDON K 30 (E 1201)",
    "TALK (E 553b)"
  ],
  "substances": [
    "EMTRICITABINE",
    "RILPIVIRINEHYDROCHLORIDE",
    "TENOFOVIRALAFENAMIDEMONOFUMARAAT"
  ],
  "leaflet_url": null,
  "authorised_at": "2025/08/19",
  "procedure_number": "EMEA/H/C/006491",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/25/1966",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about emtricitabine, tenofovir alafenamide and rilpivirine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console